Elixinol Global Ltd
Elixinol Wellness Limited, a holding company, provides healthy products in Australia, the Americas, and internationally. The company provides human nutrition, human wellness, pet wellness, and superfood ingredients under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributed through grocery, wholesale, and e-commerce channels for white… Read more
Elixinol Global Ltd (ELLXF) - Total Liabilities
Latest total liabilities as of June 2025: $9.61 Million USD
Based on the latest financial reports, Elixinol Global Ltd (ELLXF) has total liabilities worth $9.61 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Elixinol Global Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Elixinol Global Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Elixinol Global Ltd Competitors by Total Liabilities
The table below lists competitors of Elixinol Global Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ion Energy Ltd
OTCQB:IONGF
|
USA | $1.29 Million |
|
Jiuzi Holdings Inc
NASDAQ:JZXN
|
USA | $2.36 Million |
|
Niocan Inc
PINK:NIOCF
|
USA | $198.36K |
|
AB Kauno Energija
STU:WVJ
|
Germany | €111.17 Million |
|
Rotem Shani Entrepreneurship and Investments Ltd
TA:RTSN
|
Israel | ILA696.65 Million |
|
D R HORTON
MU:HO2
|
Germany | €10.00 Billion |
|
StandardCoin AS
OL:SCOIN
|
Norway | Nkr221.04K |
Liability Composition Analysis (2016–2024)
This chart breaks down Elixinol Global Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Elixinol Global Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Elixinol Global Ltd (2016–2024)
The table below shows the annual total liabilities of Elixinol Global Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $8.42 Million | +60.47% |
| 2023-12-31 | $5.25 Million | +21.31% |
| 2022-12-31 | $4.33 Million | -30.82% |
| 2021-12-31 | $6.25 Million | -8.27% |
| 2020-12-31 | $6.82 Million | -29.61% |
| 2019-12-31 | $9.69 Million | -2.73% |
| 2018-12-31 | $9.96 Million | +68.40% |
| 2017-12-31 | $5.91 Million | +34.78% |
| 2016-12-31 | $4.39 Million | -- |